BeOne Medicines AG
SSE:688235
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BeOne Medicines AG
SSE:688235
|
CH |
|
B
|
BHG Group AB
F:7B1
|
SE |
|
B
|
Bloomios Inc
OTC:BLMS
|
US |
|
Tambourah Metals Ltd
ASX:TMB
|
AU |
|
Century Lithium Corp
XTSX:LCE
|
CA |
|
Regency Centers Corp
NASDAQ:REG
|
US |
|
Majestic Corporation PLC
OTC:MCJCF
|
UK |
|
Ensign Energy Services Inc
TSX:ESI
|
CA |
|
S
|
Sumitomo Realty & Development Co Ltd
F:RL2
|
JP |
|
Paid Inc
OTC:PAYD
|
US |
|
GEK Terna SA
OTC:GKTRF
|
GR |
|
H
|
Hexatronic Group AB
DUS:02H0
|
SE |
|
R
|
Roper Technologies Inc
NASDAQ:ROP
|
US |
|
Pyridam Farma Tbk PT
IDX:PYFA
|
ID |
|
Odyssey Gold Ltd
F:ODQ
|
AU |
|
C
|
CAC Holdings Corp
F:CB4
|
JP |
|
T
|
Tyranna Resources Ltd
ASX:TYX
|
AU |
|
Mahaka Media Tbk PT
IDX:ABBA
|
ID |
Intrinsic Value
Is BeOne Medicines AG undervalued or overvalued?
See the intrinsic value estimate for BeOne Medicines AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What BeOne Medicines Does
BeiGene is a cancer drug company that discovers, develops, manufactures, and sells medicines for oncology. Its best-known products are targeted therapies and immunotherapies used to treat different kinds of blood cancers and solid tumors. The company also runs clinical trials to find new drug candidates and expand the uses of its existing medicines.
- Headquarters
- Switzerland CH
- Employees
- 12 000
- IPO date
- Mar 2, 2016
Earnings Waterfall
BeOne Medicines AG
The intrinsic value for BeOne Medicines AG (688235) under the Base Case is hidden CNY.
Compared with the current market price of 250.49 CNY, the stock appears hidden.